"Betamethasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
| Descriptor ID |
D001623
|
| MeSH Number(s) |
D04.210.500.745.432.769.199 D04.210.500.908.093
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Betamethasone".
Below are MeSH descriptors whose meaning is more specific than "Betamethasone".
This graph shows the total number of publications written about "Betamethasone" by people in this website by year, and whether "Betamethasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Betamethasone" by people in Profiles.
-
Wong W, Maher DP, Iyayi D, Lopez R, Shamloo B, Rosner H, Yumul R. Increased dose of betamethasone for transforaminal epidural steroid injections is not associated with superior pain outcomes at 4 weeks. Pain Physician. 2015 May-Jun; 18(3):E355-61.
-
Xu H, Hu F, Sado Y, Ninomiya Y, Borza DB, Ungvari Z, Lagamma EF, Csiszar A, Nedergaard M, Ballabh P. Maturational changes in laminin, fibronectin, collagen IV, and perlecan in germinal matrix, cortex, and white matter and effect of betamethasone. J Neurosci Res. 2008 May 15; 86(7):1482-500.